|
Jul 10, 2009, 07.44 PM IST
Angel Broking has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Ranbaxy Labs' consolidated June quarter sales are expected to go down by 10.2% to Rs 1,635 crore on YoY basis.
Angel Broking has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Ranbaxy Labs ' consolidated June quarter sales are expected to go down by 10.2% to Rs 1,635 crore on YoY basis.
The company's consolidated net profit is expected to go up by 4644.1% to Rs 1,086.4 crore on YoY basis.
Set email alert for Tags: Angel Broking, Ranbaxy Labs
|
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
